Blood products produced from plasma from donors in UK are still being made

Por Dash, C H
Publicado em 1998

Points: Treatment of bacterial meningitis

Por Dash, C H
Publicado em 1983

P10.23 Intraventricular pilocytic astrocytomas: Radiology, surgical management and outcome in a series of 8 patients

Por Pasricha, R., Dash, C.
Publicado no Neuro Oncol (2017)

Intrathecal penicillin.

Por Wood, F C, Dash, C
Publicado em 1978

Cephalexin: Human studies of absorption and excretion of a new cephalosporin antibiotic

Por Gower, P. E., Dash, C. H.
Publicado em 1969

Gut Flora after Cephalexin

Por Dash, C. H., Gower, P. E.
Publicado em 1970

An economical method of comparing inhaled bronchodilators in reversible diffuse airways obstruction: With special reference to a β-2 stimulant—salmefamol

Por Lal, S., Dash, C. H., Gribben, M. D.
Publicado em 1974

Betamethasone valerate compared with sodium cromoglycate in asthmatic children.

Por Ng, S. H., Dash, C. H., Savage, S. J.
Publicado em 1977

Topical glucocorticosteroids for psoriasis

Por Dash, C H, Goodspeed, A H, Sparkes, C G
Publicado em 1978

The effect of Renal Failure and Dialysis on the Pharmacokinetics of Cefuroxime

Por Gower, P E, Kennedy, Margaret R K, Dash, C H
Publicado em 1977

A survey of the sensitivity of fresh clinical isolates to cefuroxime and other antibiotics.

Por Potaschmacher, L O, Dash, C H, Jefferson, K A, Kennedy, M R
Publicado em 1979

The impact of health care advice given in primary care on cardiovascular risk. CELL Study Group.

Por Lindholm, L. H., Ekbom, T., Dash, C., Eriksson, M., Tibblin, G., Scherstén, B.
Publicado em 1995

Comparison of salmefamol and salbutamol in patients with chronic airways obstruction.

Por Campbell, I A, Dash, C H, McHardy, G J, Shotter, M V
Publicado em 1976

A double-blind trial of salmefamol, a new bronchodilator

Por Bainbridge, D., Hoare, Margaret V., McHardy, G. J. R., Dash, C. H.
Publicado em 1975

Synthesis of nucleoside 5′-O-α,β-methylene-β-triphosphates and evaluation of their potency towards inhibition of HIV-1 reverse transcriptase

Por Ahmadibeni, Y., Dash, C., Hanley, M. J., Le Grice, S. F. J., Agarwal, H. K., Parang, K.
Publicado em 2010

Sputum and blood concentrations of cefuroxime in lower respiratory tract infection.

Por Havard, C W, Bax, R P, Samanta, T C, Pearson, R M, Brumfitt, W, Hamilton-Miller, J M, Dash, C H
Publicado em 1980

The clearance kinetics of autologous RhD-positive erythrocytes coated ex vivo with novel recombinant and monoclonal anti-D antibodies

Por Chapman, G E, Ballinger, J R, Norton, M J, Parry-Jones, D R, Beharry, N A, Cousins, C, Dash, C H, Peters, A M
Publicado em 2007

Efficacy and safety of a new immunoglobulin G product, Gammaplex®, in primary immunodeficiency diseases

Por Moy, J N, Scharenberg, A M, Stein, M R, Suez, D, Roberts, R L, Levy, R J, Ballow, M, Fasano, M B, Dash, C H, Leach, S J
Publicado em 2010

Clinical assessment of Optivate(®), a high‐purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A

Por DMOSZYNSKA, A., KULICZKOWSKI, K., HELLMANN, A., TRELINSKI, J., KLOCZKO, J., BAGLIN, T., HAY, C., O’SHAUGHNESSY, D., ZAWILSKA, K., MAKRIS, M., SHAIKH‐ZAIDI, R., GASCOIGNE, E., DASH, C.
Publicado no Haemophilia (2011)